V.DOX offers a bioelectric wound‑care bandage that uses moisture‑activated silver‑zinc microcell batteries to generate low‑level micro‑currents mimicking the skin’s natural electrical potential.
Funding
$1.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Chronic and acute wounds often develop bacterial biofilm, which makes infections highly resistant to antibiotics and impedes normal healing. Current wound care relies on topical antimicrobials that are losing effectiveness as resistance rises, leaving patients at risk of prolonged infection and delayed tissue repair.
Solution
V.DOX™ is a bioelectric wound‑care bandage that incorporates moisture‑activated microcell batteries made of elemental silver and zinc to generate low‑level micro‑currents mimicking the skin’s natural transepithelial potential. The generated electric field disrupts bacterial biofilm, achieves up to 99.99 % bacterial kill without antibiotics, and promotes cell migration and re‑epithelialization. The bandage delivers continuous electroceutical therapy directly to the wound site, reducing infection risk while supporting the body’s intrinsic healing processes. Clinical and pre‑clinical studies show effectiveness against antibiotic‑resistant bacteria and fungi, including Candida albicans, and demonstrate accelerated wound closure. The product is available as an over‑the‑counter PowerHeal™ bandage and as prescription‑grade dressings for professional use.
Target Audience
Primary customers are healthcare providers—hospitals, wound‑care clinics, and surgeons—who treat acute, chronic, and post‑surgical wounds, as well as consumers seeking advanced OTC wound care for minor injuries and diabetic foot ulcers.
Features
- Patented matrix of moisture‑activated microcell batteries (silver/zinc) that wirelessly generate therapeutic micro‑currents upon contact with wound exudate
- Bioelectric field designed to replicate the skin’s physiologic transepithelial potential, enhancing cell migration and re‑epithelialization
- Antimicrobial action that kills up to 99.99 % of bacteria and disrupts biofilm formation without using antibiotics
- Demonstrated efficacy against antibiotic‑resistant pathogens, including ketoconazole‑resistant Candida albicans
- FDA‑cleared platform, available in both OTC (PowerHeal™) and prescription formats
- Integrated, single‑use dressing eliminates the need for separate power sources or external devices